Equities

Owlet Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
OWLT:NYQ

Owlet Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)11.84
  • Today's Change-0.35 / -2.87%
  • Shares traded178.69k
  • 1 Year change+163.11%
  • Beta1.7359
Data delayed at least 15 minutes, as of Mar 03 2026 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Owlet, Inc. operates as a digital parenting platform company. The Company offers FDA-authorized medical and consumer pediatric wearables and an integrated HD visual and audio camera that provide real-time data and insights to parents who safeguard health, optimize wellness, and ensure peaceful sleep for their children. Its products include Owlet Dream Sock, an app to assist children with better sleep; Owlet Cam, a video streaming app to hear and see the baby from anywhere, and Owlet Monitor Duo. Its sock monitor offerings include Smart Sock, Dream Sock and BabySat. Its Cam offerings include Cam 1 and Cam 2. Combining Dream Sock or Owlet Smart Sock with Owlet Cam, this baby monitoring solution offers HD video, sleep insights, and health tracking to offer an extensive view into an infant's well-being. Its accessories product line includes the Owlet Sleeper, a wearable rayon blanket that encourages safe sleep, best for babies ages three-six months old, and an Owlet Sock Travel Case.

  • Revenue in USD (TTM)99.64m
  • Net income in USD-42.45m
  • Incorporated2020
  • Employees80.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cibus Inc3.79m-118.90m251.91m157.00--3.87--66.40-3.26-3.260.09720.95880.0109--4.2324,165.61-36.11-80.24-39.32-89.98-----3,322.54-1,268.46---2.180.8131--134.56-10.196.07---22.92--
CapsoVision Inc13.09m-22.56m252.49m----12.34--19.29-0.4873-0.48730.28260.4368----------------53.13---172.37--4.50--0.00--20.54---76.01------
Shoulder Innovations Inc41.63m-34.45m278.74m61.00--1.88--6.70-1.91-1.912.247.18----------------76.67---82.75--9.80--0.0913--64.07---50.85------
Trubridge Inc349.88m5.42m286.22m3.20k51.411.598.930.81810.37090.370924.2312.020.8737257.086.17109,338.401.39-0.91071.60-1.0353.1650.131.59-1.141.902.400.4768--0.9464.5256.05--61.10--
Clearpoint Neuro Inc34.33m-23.14m291.53m115.00--17.55--8.49-0.8264-0.82641.230.55840.68291.957.52298,539.10-46.03-35.94-54.48-41.4861.3163.49-67.40-74.875.56-92.370.6479--31.0422.8514.37--11.41--
Quanterix Corp130.20m-95.66m295.68m471.00--0.9395--2.27-2.33-2.333.216.740.30451.444.06276,439.50-22.37-13.18-25.81-14.5351.5356.14-73.47-45.092.31--0.0029--12.3019.36-35.89---20.86--
Sight Sciences Inc76.05m-46.11m297.14m216.00--4.59--3.91-0.8955-0.89551.471.230.58541.426.71352,092.60-35.49-35.50-39.37-38.5386.8382.63-60.63-94.208.93-76.380.384---1.4727.897.27---10.54--
Delcath Systems Inc85.23m2.70m310.28m156.00142.312.79105.613.640.06280.06282.183.210.85141.377.53546,352.602.70-54.432.95-69.7186.1684.723.17-102.109.98--0.00--129.08120.21110.23--14.62--
Rxsight Inc134.48m-38.94m314.04m461.00--1.14--2.34-0.9533-0.95333.296.680.42671.175.03291,713.70-12.36-21.94-13.47-24.1076.6064.71-28.96-52.979.75--0.0003---3.8955.74-41.85--8.57--
Owlet Inc99.64m-42.45m336.21m80.00------3.37-2.75-2.756.08-2.341.523.804.361,245,500.00-60.37-64.44-244.32-331.1152.0644.29-39.68-58.720.9074-2.48----44.529.4054.08---17.23--
Senseonics Holdings Inc29.30m-63.77m340.35m117.00--4.35--11.62-1.65-1.650.75651.920.2483.625.22250,410.30-53.98-71.11-70.98-94.7541.11-14.81-217.65-594.095.93-29.180.3109--0.36621.08-30.18--16.46--
Carlsmed Inc-100.00bn-100.00bn357.41m100.00--3.33----------4.01------------------------11.91--0.1265--97.16---31.49------
Evolent Health Inc1.88bn-579.40m399.67m4.20k--0.9625--0.213-5.15-5.1516.433.720.8445--5.18446,721.20-24.06-7.51-31.98-10.2021.3120.74-28.49-8.76---0.10360.7004---26.5615.20-519.99--1.42--
Standard Biotools Inc105.90m-61.49m423.02m818.00--0.997--3.99-0.162-0.19730.27751.100.17951.804.52---10.42-23.14-12.23-27.9148.3847.79-58.06-92.674.01--0.0007---6.24-9.1957.05---8.17--
Data as of Mar 03 2026. Currency figures normalised to Owlet Inc's reporting currency: US Dollar USD

Institutional shareholders

20.47%Per cent of shares held by top holders
HolderShares% Held
AWM Investment Co., Inc.as of 31 Dec 20251.75m6.34%
The Vanguard Group, Inc.as of 31 Dec 2025717.13k2.60%
Granahan Investment Management, LLCas of 31 Dec 2025686.75k2.49%
Next Century Growth Investors LLCas of 31 Dec 2025484.91k1.76%
Cannell Capital LLCas of 31 Dec 2025431.62k1.57%
Portolan Capital Management LLCas of 31 Dec 2025343.54k1.25%
Columbia Management Investment Advisers LLCas of 31 Dec 2025317.69k1.15%
Cresset Asset Management LLCas of 31 Dec 2025316.41k1.15%
Bleichroeder LPas of 31 Dec 2025310.00k1.12%
BlackRock Fund Advisorsas of 31 Dec 2025289.66k1.05%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.